Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus
dc.contributor.author | Porter, M. | |
dc.contributor.author | Henderson, B. | |
dc.contributor.author | Healy, P. | |
dc.contributor.author | Coombs, Geoffrey | |
dc.contributor.author | Ingram, P. | |
dc.contributor.author | McLellan, D. | |
dc.contributor.author | Clark, B. | |
dc.date.accessioned | 2018-05-18T07:57:11Z | |
dc.date.available | 2018-05-18T07:57:11Z | |
dc.date.created | 2018-05-18T00:23:14Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Porter, M. and Henderson, B. and Healy, P. and Coombs, G. and Ingram, P. and McLellan, D. and Clark, B. 2014. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus. The Journal of antimicrobial chemotherapy. 69 (3): pp. 856-857. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/67098 | |
dc.identifier.doi | 10.1093/jac/dkt436 | |
dc.publisher | Oxford University Press | |
dc.title | Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus | |
dc.type | Journal Article | |
dcterms.source.volume | 69 | |
dcterms.source.number | 3 | |
dcterms.source.startPage | 856 | |
dcterms.source.endPage | 857 | |
dcterms.source.issn | 0305-7453 | |
dcterms.source.title | The Journal of antimicrobial chemotherapy | |
curtin.department | School of Pharmacy and Biomedical Sciences | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |